placeholder image
J. L. Probstfield All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Design of FLAT-SUGAR: randomized trial of prandial insulin versus prandial GLP-1 receptor agonist together with basal insulin and metformin for high-risk type 2 diabetes. 
    Diabetes care. 2015
  • Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?. 
    Journal of Clinical Hypertension (Greenwich, Conn.). 2013
  • Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). 
    Journal of Clinical Hypertension (Greenwich, Conn.). 2013
  • Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. 
    Hypertension (Dallas, Tex.. 2013
  • Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. 
    Kidney International. 2012
  • Long-term effects of intensive glucose lowering on cardiovascular outcomes. 
    New England Journal of Medicine. 2011
  • Effects of intensive blood-pressure control in type 2 diabetes mellitus. 
    New England Journal of Medicine. 2010
  • Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. 
    Diabetes care. 2010
  • ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. 
    Archives of Internal Medicine. 2009
  • Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT-LLT). 
    American Heart Journal. 2009
  • Effects of intensive glucose lowering in type 2 diabetes. 
    New England Journal of Medicine. 2008
  • Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods Am J Cardiol
    2007
  • Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Am J Cardiol
    2007
  • Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Am J Cardiol
    2007
    • Abstract
  • Glucose variability in type 2 diabetes: the initial results of the FLAT-SUGAR trial [abstract 385-OR]. 
    Diabetes. 2015
  • Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract]. 
    Diabetologia. 2011
    • presentations
    Contact
    full name
  • J. L. Probstfield
  • JL Probstfield
    • Quick Info
     
    Collaboration